The study patients: 184 patients with septic shock admitted to mixed (medical-surgical) intensive care unit (ICU). Inclusion criteria: Adult patients admitted to the ICU between January 2005 and January 2009 with septic shock, who had been investigated within the first 48 hours with both an abdominal CT scan, and cortisol concentration before and after a short cosyntropin test. After the test, all septic patients received steroids treatment with IV hydrocortisone (200 mg/24h). Exclusion criteria: Age below 18 yr; pregnancy; previous pituitary or adrenal disease; history of steroid use.
Control group: Patients without sepsis admitted to the ICU (ICU non-septic group, n=15) and ambulatory patients who had a normal virtual colonoscopy (control group, n=40).
Subgroup analysis:
Survivors vs non-survivors ICU septic patients. The analyses included 1. Multivariate logistic regression analysis to identify an
Does adrenal gland volume predict mortality in septic shock?
Adrenal gland volume may be an independent predictor of mortality in patients with septic shock Level of evidence: 2B (CEBM)
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Baseline cortisol concentration Response cortisol concentration
Adrenal gland volume r=0.09 (p=0.36) r=0.34 (p<0.001) Table 3 Results of the Pearson's Correlation analysis between adrenal gland volume and baseline and response cortisol levels.
Volume 13, Number 3, July 2012 JICS 260 CAT reviews independent risk factor for mortality 2. ROC analysis to identify the adrenal gland volume that could best predict mortality 3. Kaplan-Meier analysis to produce survival curves of patients according to adrenal gland volume, basal and response plasma cortisol.
EBM questions: 1. Do the methods allow accurate testing of the hypothesis? Yes, but with some limitations. In this study, the authors presented data suggesting that adrenal gland volume is an independent predictor of mortality in patients with septic shock. The study also found a weak correlation between adrenal gland volume and response cortisol levels. However, all septic patients received steroid therapy during their ICU admission. Therefore, it is impossible to speculate on the volume of adrenal gland in septic patients who were not treated with steroids. 2. Do the statistical tests correctly test the results to allow differentiation of statistically significant results? Yes, but some relevant tests were omitted. The authors used a multivariate logistic regression analysis to identify independent risk factors of mortality during sepsis. The correlation between cosyntropin test results and adrenal gland volume measurements was assessed with the Pearson correlation coefficient. Receiver operating characteristics (ROC) curves were used to calculate sensitivity and specificity of adrenal gland volume and basal/response plasma cortisol levels as predictors of mortality. Survival curves were calculated using the Kaplan-Meier method and comparisons were made between groups with the log-rank test. Although the statistical tests used were appropriate, there are some caveats. Firstly, the logistic regression model should have included only variables statistically different in survivors and nonsurvivors. Instead, the authors included variables that were not significantly different (eg age, sex, comorbidities, and basal and plasma cortisol concentration, p>0.05). So, it is not surprising that these variables were not significant predictors of mortality. Conversely, the authors did not include platelet count in the model, which was statistically different in survivors and non-survivors (p=0.004) and could, potentially, be a significant predictor of mortality. Secondly, the authors do not provide any p-value for the results of the multiple logistic regression analysis. Finally, the authors presented results of the comparison between adrenal gland volume (greater and less than 10 cm 3 ) at different levels of plasma response cortisol (greater and less than 9 µg/dL). The results show 68% of the patients with low cortisol response and low adrenal gland volume died before day 28, whereas only 14% of the patients with high plasma cortisol response and a high adrenal gland volume died before day 28 (p<0.0001). In addition, 78% of the patients with a high plasma cortisol and a low adrenal volume died before day 28, whereas only 68% of the patients with a low cortisol and low adrenal volume died before day 28. This would suggest a role of the response to cortisol in mortality. Yet, the authors do not provide any statistical comparison for this latter result and do not comment on the statistical significance of the mortality in the two groups. 3. Are the conclusions valid in light of the results? Yes. The authors found that the adrenal gland volume is an independent prognostic factor for 28-day mortality. Furthermore, they found that septic patients with an adrenal gland volume less than 10 cm 3 have a higher risk of death. The authors found a weak, but statistically significant, correlation between adrenal gland volume and cortisol response. From these findings the authors conclude that a CT scan to assess adrenal gland volume may be of prognostic value, with adrenal gland volume less than 10 cm 3 being an identifier of high-risk patients. These conclusions correlate with the findings. 4. Did results get omitted? Yes. During the study period, 470 patients were admitted to ICU with septic shock. Of these, 266 were excluded from the study because they either did not have a cosyntropin test or a CT scan, or had a CT scan after the first 48 hours of shock. Furthermore, as acknowledged by the authors, the analyses highlighting the association between adrenal gland volume and mortality did not include patients who did not have septic shock or patients acutely treated with steroids. This could be considered a limitation of the study. 5. Did they suggest further areas of research? Yes. The authors recognise that further studies are needed to evaluate the association between adrenal gland volume and cosyntrophin stimulation test in other populations at high risk of corticosteroid insufficiency in ICU settings, such as brain dead or trauma patients. 6. Did they make any recommendations based on the results and were they appropriate? No. 7. Is the study relevant to my clinical practice? Yes to some extent. The issue of steroid supplementation in patients with septic shock remains controversial. This study will contribute to the debate by establishing a credible link between adrenal gland size and mortality in ICU patients with septic shock. However, the important question of whether adrenal gland size is a predictor of plasma cortisol response remains unanswered, rendering the results of less use for clinical practice. From this study alone it is not possible to draw any conclusions or recommendations as to whether steroids should be given to patients with small adrenal glands. 8. What level of evidence does this study represent? This is a single centre observational study. Therefore, it represents a 2B level of evidence according to the CEBM criteria. 9. What grade of recommendation can I make on this study alone? C (according to the CEBM criteria) 10. What grade of recommendation can I make when this study is considered with other available evidence? B (according to the CEBM criteria) 11. Should I change my practice because of these results? Not yet.
More data are needed to support the practice to perform abdominal CT scan for measurement of adrenal gland volume as a prognostic indicator of mortality in septic shock. 12. Should I audit my current practice? No.
